Arteriocyte gets FDA approval to begin critical limb ischemia clinical trial
Stem cell developer Arteriocyte has received approval from the U.S. Food and Drug Administration to begin a clinical trial for the treatment of critical limb ischemia.
Arteriocyte launches stem cell-based blood research product
Arteriocyte Inc. has launched a stem cell-based product that allows researchers to grow red blood cells outside the human body.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Stem cell developer Arteriocyte grows up: Q&A with CEO Don Brown
Don Brown, CEO of Cleveland-based stem cell company Arteriocyte, discusses his company's progress towards getting its therapies on the market and its priorities going forward.